Overview

A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients

Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
To test the effectiveness of MNTX in advanced illness subjects.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.
Collaborator:
Pfizer
Treatments:
Methylnaltrexone
Naltrexone